Differences in sensitivity to new therapies between primary and metastatic breast cancer: A need to stratify the tumor response?

Differences in sensitivity to new therapies between primary and metastatic breast cancer: A need to stratify the tumor response?

Abstract Objective We compared therapeutic response of Varlitinib + Capecitabine (VC) versus Lapatinib + Capecitabine (LC) in patients with human epidermal growth factor receptor 2‐positive metastatic breast cancer after trastuzumab therapy by assessing changes in target lesion (TL) diameter and vol...

Full description

Saved in:
Bibliographic Details
Main Authors: Hubert Beaumont, Nathalie Faye, Antoine Iannessi, Emmanuel Chamorey, Catherine Klifa, Chih‐Yi Hsieh
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:Cancer Medicine
Subjects:
biomarkers
Breast Neoplasms
Multidetector Computed Tomography
Tumor burden
Online Access:https://doi.org/10.1002/cam4.5236
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items